Item 9 Labs Corp.
INLB
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -8.06% | 11.90% | 2.61% | -103.94% | -556.01% |
| Total Depreciation and Amortization | -13.25% | -5.81% | 0.29% | -40.51% | 302.34% |
| Total Amortization of Deferred Charges | -14.58% | -32.20% | -49.06% | -55.01% | 99.35% |
| Total Other Non-Cash Items | -0.64% | -45.50% | -72.13% | 683.39% | 278.93% |
| Change in Net Operating Assets | 372.19% | 4.65% | -26.71% | -5.71% | 136.91% |
| Cash from Operations | 106.28% | -52.83% | -398.54% | -126.83% | 0.32% |
| Capital Expenditure | -119.84% | 100.20% | 99.73% | -6,745.75% | 120.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 96.33% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 667.86% | -- |
| Cash from Investing | -125.84% | 100.06% | 99.53% | -2,007.12% | 115.95% |
| Total Debt Issued | -92.45% | -100.50% | 6.50% | 74.14% | -- |
| Total Debt Repaid | 81.17% | 75.78% | 70.05% | -3.48% | -146.75% |
| Issuance of Common Stock | -- | -- | -- | 220.44% | -21.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -98.56% | -- | -- | -22.00% | -- |
| Cash from Financing | -100.20% | -111.97% | 209.27% | 278.95% | 2,874.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -75.54% | 242.81% | 95.06% | -130.75% | 108.39% |